Skip to main content
. 2023 Aug 4;72(8):1709–1717. doi: 10.1007/s00011-023-01774-4

Fig. 5.

Fig. 5

PR3 activity in mouse BALF neutrophil lysate after treatment with BI 1291583 and subsequent LPS challenge, 11-day dosing. BALF bronchoalveolar lavage fluid, LPS lipopolysaccharide, p.o. orally, RFU relative fluorescence units, PR3 proteinase 3. ***p < 0.001 compared with vehicle. Samples were pooled for analysis of PR3 activity. Data are mean. Error bars depict standard error of the mean across duplicate experiments